The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4 — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4 — Stella

Home/Hereditary Spastic Paraplegia/

View on ClinicalTrials.gov

Recruiting

Back to Hereditary Spastic Paraplegia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Germany

University Hospital Tübingen, Center for Neurology, Tübingen

Key details

Sponsor

University Hospital Tuebingen

Enrollment target

~200 participants

Started

July 2018

Primary completion

December 2029

Age range

18 Years – 70 Years

Last updated August 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.